189 related articles for article (PubMed ID: 7514539)
1. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
Kochhar KS; Linnekin D; Iyer AP
Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
[TBL] [Abstract][Full Text] [Related]
2. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PDGF-induced phospholipase D but not phospholipase C activation by herbimycin A.
Kim BY; Ahn SC; Oh HK; Lee HS; Mheen TI; Rho HM; Ahn JS
Biochem Biophys Res Commun; 1995 Jul; 212(3):1061-7. PubMed ID: 7626093
[TBL] [Abstract][Full Text] [Related]
4. STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.
Sachsenmaier C; Sadowski HB; Cooper JA
Oncogene; 1999 Jun; 18(24):3583-92. PubMed ID: 10380880
[TBL] [Abstract][Full Text] [Related]
5. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
Benito M; Lorenzo M
Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
[TBL] [Abstract][Full Text] [Related]
6. Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity.
Wang YZ; Wharton W; Garcia R; Kraker A; Jove R; Pledger WJ
Oncogene; 2000 Apr; 19(17):2075-85. PubMed ID: 10815799
[TBL] [Abstract][Full Text] [Related]
7. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PDGF-induced phosphoinositide-turnover by glucopiericidin A.
Ahn SC; Kim BY; Park CS; Lee HS; Suh PG; Ryu SH; Rho HM; Rhee JS; Mheen TI; Ahn JS
Biochem Mol Biol Int; 1995 Sep; 37(1):125-32. PubMed ID: 8653074
[TBL] [Abstract][Full Text] [Related]
9. Detection of activated platelet-derived growth factor receptors in human meningioma.
Shamah SM; Alberta JA; Giannobile WV; Guha A; Kwon YK; Carroll RS; Black PM; Stiles CD
Cancer Res; 1997 Sep; 57(18):4141-7. PubMed ID: 9307305
[TBL] [Abstract][Full Text] [Related]
10. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF.
Lopez-Ilasaca M; Li W; Uren A; Yu JC; Kazlauskas A; Gutkind JS; Heidaran MA
Biochem Biophys Res Commun; 1997 Mar; 232(2):273-7. PubMed ID: 9125162
[TBL] [Abstract][Full Text] [Related]
11. PDGF-induced phosphorylation of Tyr28 in the N-terminus of Fyn affects Fyn activation.
Hansen K; Alonso G; Courtneidge SA; Rönnstrand L; Heldin CH
Biochem Biophys Res Commun; 1997 Dec; 241(2):355-62. PubMed ID: 9425276
[TBL] [Abstract][Full Text] [Related]
12. Modulation of platelet-derived growth factor receptor function in BP3T3, a chemically transformed BALB/c-3T3 cell line.
Grundy P; Bishayee S; Disa S; Scher CD
Cancer Res; 1989 Jul; 49(13):3581-6. PubMed ID: 2543499
[TBL] [Abstract][Full Text] [Related]
13. Expression of platelet-derived growth factor-independent phenotypes in BALB/c 3T3 cell variant with high susceptibility to chemically or physically induced neoplastic cell transformation: dissociation from activation of protein kinase C.
Tatsuka M; Owada MK; Mitsui H
Cancer Res; 1992 Aug; 52(15):4232-41. PubMed ID: 1638537
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalization of autocrine signal transduction pathways in Sis-transformed NIH 3T3 cells.
Valgeirsdóttir S; Eriksson A; Nistér M; Heldin CH; Westermark B; Claesson-Welsh L
J Biol Chem; 1995 Apr; 270(17):10161-70. PubMed ID: 7730319
[TBL] [Abstract][Full Text] [Related]
15. PDGF induces c-myc mRNA expression in MG-63 human osteosarcoma cells but does not stimulate cell replication.
Womer RB; Frick K; Mitchell CD; Ross AH; Bishayee S; Scher CD
J Cell Physiol; 1987 Jul; 132(1):65-72. PubMed ID: 2439522
[TBL] [Abstract][Full Text] [Related]
16. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions.
Heidaran MA; Beeler JF; Yu JC; Ishibashi T; LaRochelle WJ; Pierce JH; Aaronson SA
J Biol Chem; 1993 May; 268(13):9287-95. PubMed ID: 8387491
[TBL] [Abstract][Full Text] [Related]
17. Identification of a PDGF-like mitoattractant produced by NIH/3T3 cells after transformation with SV40.
Bleiberg I; Harvey AK; Smale G; Grotendorst GR
J Cell Physiol; 1985 May; 123(2):161-6. PubMed ID: 2984217
[TBL] [Abstract][Full Text] [Related]
18. Cells transformed by ODC, c-Ha-ras and v-src exhibit MAP kinase/Erk-independent constitutive phosphorylation of Sos, Raf and c-Jun activation domain, and reduced PDGF receptor expression.
Paasinen-Sohns A; Hölttä E
Oncogene; 1997 Oct; 15(16):1953-66. PubMed ID: 9365242
[TBL] [Abstract][Full Text] [Related]
19. Phosphotyrosine antibodies as probes for activated oncogene products endowed with tyrosine kinase activity.
Prat M; Di Renzo MF; Gaudino G; Ponzetto C; Comoglio PM
Ann Ist Super Sanita; 1991; 27(1):175-81. PubMed ID: 1720292
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phosphotyrosine phosphatases reveals candidate substrates of the PDGF receptor kinase.
Zippel R; Morello L; Brambilla R; Comoglio PM; Alberghina L; Sturani E
Eur J Cell Biol; 1989 Dec; 50(2):428-34. PubMed ID: 2560717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
